Oder Investment Management, LLC Amgen Inc Transaction History

Oder Investment Management, LLC

$115 Million
Q3 2024

A detailed history of Oder Investment Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Oder Investment Management, LLC holds 905 shares of AMGN stock, worth $266,070. This represents 0.25% of its overall portfolio holdings.

Number of Shares

905

Previous 919 1.52%

Holding current value

$266,070

Previous $287,000 1.39%

% of portfolio

0.25%

Previous 0.26%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $4,331 - $4,723	-14 Reduced 1.52%	905 $291,000
Q2 2024 Aug 08, 2024	SELL	$262.75 - $319.31 $262 - $319	-1 Reduced 0.11%	919 $287,000
Q4 2023 Feb 05, 2024	BUY	$255.7 - $288.46 $255 - $288	1 Added 0.11%	920 $264,000
Q3 2023 Nov 07, 2023	SELL	$218.65 - $271.46 $8,964 - $11,129	-41 Reduced 4.27%	919 $246,000
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $18,212 - $21,536	-85 Reduced 8.13%	960 $213,000
Q1 2023 May 11, 2023	BUY	$225.79 - $275.2 $4,515 - $5,504	20 Added 1.95%	1,045 $252,000
Q4 2022 Feb 07, 2023	SELL	$229.03 - $291.01 $39,622 - $50,344	-173 Reduced 14.44%	1,025 $269,000
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $276,390 - $307,574	1,198 New	1,198 $291,000
Q3 2021 Nov 15, 2021	SELL	$212.27 - $248.7 $623,649 - $730,680	-2,938 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $3,503 - $3,887	15 Added 0.51%	2,938 $716,000
Q1 2021 May 10, 2021	BUY	$221.91 - $258.6 $1,997 - $2,327	9 Added 0.31%	2,923 $727,000
Q4 2020 Feb 11, 2021	BUY	$216.38 - $257.67 $630,531 - $750,850	2,914 New	2,914 $667,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $157B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oder Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Oder Investment Management, LLC with notifications on news.

Account

Oder Investment Management, LLC Amgen Inc Transaction History